ghk-cu clinical trials side effects Effects: What Does the Research Say? Doctor Explains Can GHK-Cu Be Taken Orally?

With repeated administrations leading to a buildup effect

Predictably, results showed that different doses of Dihexa-treated APP/PS1 mice increased the levels of AngIV

The good news is that outcome is quite rare

Your bloods may come back as fine but your cellular levels may not be adequate

Each product has a third party tested Certificate of Analysis (COA)

The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough